Cholesterol-independent Effects of Statins and New Therapeutic Targets: Ischemic Stroke and Dementia

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Prediction of coronary heart disease using risk factor categories

Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · see citing works

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467 · see citing works

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449 · see citing works

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439 · see citing works

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992 · see citing works

A Receptor-Mediated Pathway for Cholesterol Homeostasis

Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703 · see citing works

Regulation of the mevalonate pathway

Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394 · see citing works

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261 · see citing works

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,285 · see citing works

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · see citing works

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Sever, P., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M. J., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,757 · see citing works

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638 · see citing works

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378 · see citing works

Rho GTPases and signaling networksPreprint

Aelst, L. V., & D’Souza‐Schorey, C. (1997) · Genes & Development · doi:10.1101/gad.11.18.2295 · Cited by 2,358 · see citing works

Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors

Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837 · see citing works

Stimulation of Bone Formation in Vitro and in Rodents by Statins

Mundy, G. R., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B. F., Zhao, M., & Gutierrez, G. (1999) · Science · doi:10.1126/science.286.5446.1946 · Cited by 1,776 · see citing works

Statins and the risk of dementia

Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,763 · see citing works

Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., & D, E. B. M. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,479 · see citing works

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D. J., Lefer, D. J., Sessa, W. C., & Walsh, K. X. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,438 · see citing works

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389 · see citing works

Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors

Wolozin, B. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,386 · see citing works

Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.

Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,210 · see citing works

Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo

Fassbender, K. C., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., Runz, H., Kühl, S., Bertsch, T., von Bergmann, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081620098 · Cited by 1,078 · see citing works

Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase

Laufs, U., & Liao, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24266 · Cited by 1,035 · see citing works

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C., Buerk, D. G., Huang, P. L., & Jain, R. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041359198 · Cited by 1,020 · see citing works

Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease

Brown, B., Zhao, X., Sacco, D., & Albers, J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 886 · see citing works

Translational Control of p27 Kip1 Accumulation During the Cell Cycle

Hengst, L., & Reed, S. I. (1996) · Science · doi:10.1126/science.271.5257.1861 · Cited by 846 · see citing works

Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)

(1998) · Circulation · doi:10.1161/01.cir.97.15.1440 · Cited by 791 · see citing works

Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory

Turner, P. R., O’Connor, K., Tate, W. P., & Abraham, W. C. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00089-3 · Cited by 751 · see citing works

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

Kivipelto, M., Helkala, E.-L., Hänninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · Neurology · doi:10.1212/wnl.56.12.1683 · Cited by 717 · see citing works

Relative Frequencies of Alzheimer Disease, Lewy Body, Vascular and Frontotemporal Dementia, and Hippocampal Sclerosis in the State of Florida Brain Bank

Barker, W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., Waters, C., Jimison, P., Shepherd, E., Sevush, S., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200210000-00001 · Cited by 706 · see citing works

HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells

Llevadot, J., Murasawa, S., Kureishi, Y., Uchida, S., Masuda, H., Kawamoto, A., Walsh, K., Isner, J. M., & Asahara, T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13131 · Cited by 701 · see citing works

Statins Have Biphasic Effects on Angiogenesis

Weis, M., Heeschen, C., Glassford, A. J., & Cooke, J. P. (2002) · Circulation · doi:10.1161/hc0602.103393 · Cited by 677 · see citing works

Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

Notkola, I.-L., Sulkava, R. O., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 666 · see citing works

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

Wong, W. W.-L., Dimitroulakos, J., Minden, M., & Penn, L. Z. (2002) · Leukemia · doi:10.1038/sj.leu.2402476 · Cited by 579 · see citing works

Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol

Sparks, D. L., Scheff, S. W., Hunsaker, J. C., Liu, H., Landers, T. M., & Gross, D. R. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1044 · Cited by 559 · see citing works

Blood pressure, cholesterol, and stroke in eastern Asia

Xu, Z., Sasaki, R., Wang, S., Ling, Y., Wu, X., Wu, Y., Lam, T., Xie, J., He, Y., Zhou, B., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03454-0 · Cited by 532 · see citing works

Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People

Rockwood, K. J., Kirkland, S., Hogan, D. B., MacKnight, C., Merry, H. R., Verreault, R., Wolfson, C. M., & McDowell, I. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.223 · Cited by 517 · see citing works

Native Low-Density Lipoprotein Increases Endothelial Cell Nitric Oxide Synthase Generation of Superoxide Anion

Pritchard, K. A., Groszek, L., Smalley, D. M., Sessa, W. C., Wu, M., Villalon, P., Wolin, M. S., & Stemerman, M. B. (1995) · Circulation Research · doi:10.1161/01.res.77.3.510 · Cited by 471 · see citing works

ADAMs family members as amyloid precursor protein α‐secretases

Allinson, T. M. J., Parkin, E. T., Turner, A. J., & Hooper, N. M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10737 · Cited by 441 · see citing works

Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance

Féron, O., Dessy, C., Desager, J., & Balligand, J. (2001) · Circulation · doi:10.1161/01.cir.103.1.113 · Cited by 418 · see citing works

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trial

Simons, M., Schwärzler, F., Lütjohann, D., von Bergmann, K., Beyreuther, K. T., DICHGANS, J., Wormstall, H., Hartmann, T., & Schulz, J. B. (2002) · Annals of Neurology · doi:10.1002/ana.10292 · Cited by 415 · see citing works

Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme

Gil, G., Faust, J. R., Chin, D. J., Goldstein, J. L., & Brown, M. S. (1985) · Cell · doi:10.1016/0092-8674(85)90078-9 · Cited by 386 · see citing works

Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol

Goldstein, J. L., & Brown, M. S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34418-7 · Cited by 383 · see citing works

3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27

Laufs, U., Marra, D. E., Node, K., & Liao, J. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21926 · Cited by 381 · see citing works

Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.

Egashira, K., Inou, T., Hirooka, Y., Yamada, A., Maruoka, Y., Kai, H., Sugimachi, M., Suzuki, S. O., & Takeshita, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116183 · Cited by 357 · see citing works

The Münster Heart Study (PROCAM). Results of follow-up at 8 years.

Assmann, G., Cullen, P., & Schulte, H. (1998) · PubMed · Cited by 334 · see citing works

Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease.

Werns, S. W., Walton, J. A., Hsia, H. H., Nabel, E. G., Sanz, M. L., & Pitt, B. (1989) · Circulation · doi:10.1161/01.cir.79.2.287 · Cited by 322 · see citing works

Role of Endothelial Nitric Oxide Synthase in Endothelial Cell Migration

Murohara, T., Witzenbichler, B., Spyridopoulos, I., Asahara, T., Ding, B., Sullivan, A. B., Losordo, D. W., & Isner, J. M. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1156 · Cited by 319 · see citing works

Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß ₄₂ by Inhibiting Rho

Zhou, Y., Su, Y., Li, B., Liu, F., Ryder, J. W., Wu, X., Gonzalez-DeWhitt, P. A., Gelfanova, V., Hale, J. E., May, P. C., et al. (2003) · Science · doi:10.1126/science.1090154 · Cited by 316 · see citing works

Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum.

Liscum, L., Finer-Moore, J. S., Stroud, R. M., Luskey, K. L., Brown, M. S., & Goldstein, J. L. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89764-2 · Cited by 308 · see citing works

Double-Edged Role of Statins in Angiogenesis Signaling

Urbich, C., Dernbach, E., Zeiher, A. M., & Dimmeler, S. (2002) · Circulation Research · doi:10.1161/01.res.0000014081.30867.f8 · Cited by 305 · see citing works

Beyond lipid lowering: the role of statins in vascular protection

Liao, J. K. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00195-x · Cited by 261 · see citing works

Nucleotide sequence of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase, a glycoprotein of endoplasmic reticulum

Chin, D. J., Gil, G., Russell, D. W., Liscum, L., Luskey, K. L., Basu, S. K., Okayama, H., Berg, P. R., Goldstein, J. L., & Brown, M. S. (1984) · Nature · doi:10.1038/308613a0 · Cited by 257 · see citing works

Cerivastatin, a Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor, Improves Endothelial Function in Elderly Diabetic Patients Within 3 Days

Tsunekawa, T., Hayashi, T., Kano, H., Sumi, D., Matsui‐Hirai, H., Thakur, N. K., Egashira, K., & Iguchi, A. (2001) · Circulation · doi:10.1161/hc2901.094094 · Cited by 256 · see citing works

Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene.

Smith, J. R., Osborne, T. F., Goldstein, J. L., & Brown, M. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39976-4 · Cited by 236 · see citing works

Prevalence of Dementia and Its Subtypes in the Japanese American Population of King County, Washington State: The Kame Project

Graves, A. B., Larson, E. B., Edland, S. D., Bowen, J., McCormick, W. C., McCurry, S. M., Rice, M. M., Wenzlow, A. T., & Uomoto, J. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009000 · Cited by 233 · see citing works

Prevalence and etiology of dementia in a Japanese community.

Ueda, K., Kawano, H., Hasuo, Y., & Fujishima, M. (1992) · Stroke · doi:10.1161/01.str.23.6.798 · Cited by 199 · see citing works

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase

Blum, C. B. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90626-2 · Cited by 192 · see citing works

HMG-CoA Reductase Inhibitor Modulates Monocyte–Endothelial Cell Interaction Under Physiological Flow Conditions In Vitro

Yoshida, M., Sawada, T., Ishii, H., Gerszten, R. E., Rosenzweig, A., Gimbrone, M. A., Yasukochi, Y., & Numano, F. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0701.092143 · Cited by 187 · see citing works

Beyond lipid-lowering: effects of statins on endothelial nitric oxide

Laufs, U. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0556-0 · Cited by 185 · see citing works

Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study

Amarenco, P., Bogousslavsky, J., Callahan, A. S., III, Goldstein, L. B., Hennerici, M. G., Sillsen, H., Welch, M. A., & Zivin, J. A. (2003) · Cerebrovascular Diseases · doi:10.1159/000072562 · Cited by 183 · see citing works

Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial Function

Wassmann, S., Faul, A., Hennen, B., Scheller, B., Böhm, M., & Nickenig, G. (2003) · Circulation Research · doi:10.1161/01.res.0000099503.13312.7b · Cited by 177 · see citing works

Reduction in Levels of 24S-Hydroxycholesterol by Statin Treatment in Patients With Alzheimer Disease

Vega, G. L., Weiner, M., Lipton, A. M., von Bergmann, K., Lütjohann, D., Moore, C. B., & Svetlik, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.510 · Cited by 172 · see citing works

Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?

Massy, Z. A., Keane, W. F., & Kasiske, B. L. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90217-2 · Cited by 160 · see citing works

Loss of transcriptional repression of three sterol-regulated genes in mutant hamster cells

Metherall, J. E., Goldstein, J. L., Luskey, K. L., & Brown, M. S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84879-2 · Cited by 159 · see citing works

Direct Vascular Effects of HMG-CoA Reductase Inhibitors

Laufs, U. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00044-x · Cited by 157 · see citing works

Reduction of Plasma 24S-Hydroxycholesterol (Cerebrosterol) Levels Using High-Dosage Simvastatin in Patients With Hypercholesterolemia

Locatelli, S., Lütjohann, D., Schmidt, H., Otto, C., Beisiegel†, U., & von Bergmann, K. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.213 · Cited by 152 · see citing works

Plasma 24S-hydroxycholesterol

Papassotiropoulos, A., Lütjohann, D., Bagli, M., Locatelli, S., Jessen, F., Rao, M. L., Maier, W., Björkhem, I., von Bergmann, K., & Heun, R. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00030 · Cited by 145 · see citing works

Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta.

Mangin, E., Kugiyama, K., Nguy, J. H., Kerns, S. A., & Henry, P. D. (1993) · Circulation Research · doi:10.1161/01.res.72.1.161 · Cited by 144 · see citing works

Contributions of the framingham study to the conquest of coronary artery disease

Kannel, W. B. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90558-9 · Cited by 140 · see citing works

Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin

Wong, W. W.-L., Tan, M. M., Xia, Z., Dimitroualakos, J., Minden, M. D., & Penn, L. Z. (2001) · PubMed · doi:10.5167/uzh-58181 · Cited by 129 · see citing works

Molecular Cloning and Functional Analysis of the Promoter of the Human Squalene Synthase Gene

Guan, G., Jiang, G., Koch, R. L., & Shechter, I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21958 · Cited by 108 · see citing works

Treatment with Simvastatin in Patients with Alzheimer’s Disease Lowers Both α- and β-Cleaved Amyloid Precursor Protein

Sjögren, M. J. C., Gustafsson, K., Syversen, S., Olsson, A., Edman, Å., Davidsson, P., Wallin, A., & Blennow, K. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000069989 · Cited by 107 · see citing works

Degradation of 3-Hydroxy-3-methylglutaryl-CoA Reductase in Endoplasmic Reticulum Membranes Is Accelerated as a Result of Increased Susceptibility to Proteolysis

McGee, T. P., Cheng, H. H., Kumagai, H., Ōmura, S., & Simoni, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25630 · Cited by 103 · see citing works

Pharmacology of 3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Inhibitors (Statins), Including Rosuvastatin and Pitavastatin

Igel, M., Sudhop, T., & von Bergmann, K. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002401102731 · Cited by 100 · see citing works

HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier.

Sparks, D. L., Connor, D. J., Browne, P. J., Lopez, J. E., & Sabbagh, M. N. (2002) · PubMed · Cited by 82 · see citing works

Single nucleotide resolution of sterol regulatory region in promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase

Osborne, T. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92794-8 · Cited by 73 · see citing works

A Comparison of Low Versus Standard Dose Pravastatin Therapy for the Prevention of Cardiovascular Events in the Elderly : The Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE)

Ito, H., Ouchi, Y., Ohashi, Y., Saito, Y., Ishikawa, T., Nakamura, H., & Orimo, H. (2001) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.8.33 · Cited by 73 · see citing works

Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy

Enbergs, A. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1763 · Cited by 70 · see citing works

Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease

Dominguez, D. I., & Strooper, B. D. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02038-2 · Cited by 68 · see citing works

Management of dyslipidemia

Gotto, A. M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01085-9 · Cited by 66 · see citing works

Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years

Shaten, B. J., Kuller, L. H., & Neaton, J. D. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90061-8 · Cited by 63 · see citing works

Types of Change in Coronary Stenosis Severity and Their Relative Importance in Overall Progression and Regression of Coronary Disease: Observations from the FATS Trial^a

BROWN, B. G., HILLGER, L., ZHAO, X., POULIN, D., & ALBERS, J. J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17337.x · Cited by 61 · see citing works

SREBP-2 and NF-Y are involved in the transcriptional regulation of squalene epoxidase

Nagai, M., Sakakibara, J., Nakamura, Y., Gejyo, F., & Ono, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00623-x · Cited by 57 · see citing works

Transcriptional Regulation of Squalene Epoxidase by Sterols and Inhibitors in HeLa Cells

Nakamura, Y., Sakakibara, J., Izumi, T., Shibata, A., & Ono, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8053 · Cited by 56 · see citing works

Molecular cloning and promoter analysis of the rat liver farnesyl diphosphate synthase gene.

Spear, D. H., Kutsunai, S. Y., Correll, C. C., & Edwards, P. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49735-4 · Cited by 55 · see citing works

Control of signal transduction and morphogenesis by Ras

Hughes, D. A. (1995) · Seminars in Cell Biology · doi:10.1016/1043-4682(95)90005-5 · Cited by 48 · see citing works

Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl

Waßmann, S., Ribaudo, N., Faul, A., Laufs, U., Böhm, M., & Nickenig, G. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.018 · Cited by 48 · see citing works

Potential Role of Statins in Inflammation and Atherosclerosis

Yoshida, M. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.140 · Cited by 46 · see citing works

Raising high-density lipoprotein cholesterol with niacin and fibrates: a comparative review

Sprecher, D. L. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01470-3 · Cited by 37 · see citing works

Probucol

Pfuetze, K. D., & Dujovne, C. A. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0094-0 · Cited by 23 · see citing works

Modification of coronary artery disease progression by cholesterol-lowering therapy: the angiographic studies.

Archbold, R., & Timmis, A. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199912000-00008 · Cited by 22 · see citing works

Further Evidence of Westernization of Dementia Prevalence in Nagasaki, Japan, and Family Recognition

Hatada, K., Okazaki, Y., Yoshitake, K., Takada, K., & Nakane, Y. (1999) · International Psychogeriatrics · doi:10.1017/s1041610299005682 · Cited by 15 · see citing works

The Lescol Intervention Prevention Study (LIPS): start all patients on statins early after PCI.

Messerli, A. W., Aronow, H. D., & Sprecher, D. L. (2003) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.70.6.561 · Cited by 11 · see citing works

[Current practice in low-density lipoprotein-cholesterol measurements for the clinical management of hyperlipidemia].

Nakamura, Y., Miida, T., Hanyu, O., Sasagawa, Y., Suzuki, K., & Aizawa, Y. (2003) · PubMed · Cited by 2 · see citing works

Mouse Models for Atherosclerosis and Pharmaceutical Modifiers

Zadelaar, S., Kleemann, R., Verschuren, L., der Weij, J. D. V.-V., van der Hoorn, J., Princen, H. M. G., & Kooistra, T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142570 · Cited by 526 · see citing works

Statin treatment withdrawal in ischemic stroke

Blanco, M., Nombela, F., Castellanos, M., Rodríguez‐Yáñez, M., García-Gil, M., Leira, R., Lizasoaín, I., Serena, J. L., Vivancos, J., Moro, M. Á., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000269789.09277.47 · Cited by 330 · see citing works

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

Cramer, C., Haan, M. N., Galea, S., Langa, K. M., & Kalbfleisch, J. D. (2008) · Neurology · doi:10.1212/01.wnl.0000319647.15752.7b · Cited by 254 · see citing works

Mechanisms of Statin-mediated Inhibition of Small G-protein Function

Cordle, A., Koenigsknecht-Talboo, J., Wilkinson, B., Limpert, A., & Landreth, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505268200 · Cited by 235 · see citing works

Statins Promote the Degradation of Extracellular Amyloid β-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion

Tamboli, I. Y., Barth, E., Christian, L., Siepmann, M., Kumar, S., Singh, S., Tolksdorf, K., Heneka, M. T., Lütjohann, D., Wunderlich, P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149468 · Cited by 219 · see citing works

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy

McGirt, M. J., Perler, B. A., Brooke, B. S., Woodworth, G. F., Coon, A. L., Jain, S., Buck, D. W., Roseborough, G. S., Tamargo, R. J., Heller, J., et al. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.08.039 · Cited by 188 · see citing works

To be or not to be (inflamed)—is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?

Marchetti, B., & Abbracchio, M. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.08.007 · Cited by 175 · see citing works

In Vivo Imaging of Mineral Deposition in Carotid Plaque Using 18F-Sodium Fluoride PET/CT: Correlation with Atherogenic Risk Factors

Derlin, T., Wisotzki, C., Richter, U., Apostolova, I. I., Bannas, P., Weber, C., Mester, J., & Klutmann, S. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.081208 · Cited by 166 · see citing works

The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats

Gojo, A., Utsunomiya, K., Taniguchi, K., Yokota, T., Ishizawa, S., Kanazawa, Y., Kurata, H., & Tajima, N. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.011 · Cited by 149 · see citing works

Keynote review: The adipocyte as a drug discovery target

Nawrocki, A. R., & Scherer, P. E. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03569-5 · Cited by 140 · see citing works

Statins Attenuate Ischemia-Reperfusion Injury by Inducing Heme Oxygenase-1 in Infiltrating Macrophages

Gueler, F., Park, J.-K., Rong, S., Kirsch, T., Lindschau, C., Zheng, W. S., Elger, M., Fiebeler, A., Fliser, D., Luft, F. C., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060782 · Cited by 122 · see citing works

Lovastatin Has Significant Activity against Zygomycetes and Interacts Synergistically with Voriconazole

Chamilos, G., Lewis, R. E., & Kontoyiannis, D. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.96-103.2006 · Cited by 121 · see citing works

Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathway

Ahn, K. S., Sethi, G., & Aggarwal, B. B. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.010 · Cited by 114 · see citing works

Hypocholesterolemic and antioxidative effects of naringenin and its two metabolites in high-cholesterol fed rats

Jeon, S.-M., Kim, H., Kim, H.-J., Do, G., Jeong, T., Park, Y. B., & Choi, M. (2006) · Translational research · doi:10.1016/j.trsl.2006.08.001 · Cited by 112 · see citing works

Increased Membrane Cholesterol Might Render Mature Hippocampal Neurons More Susceptible to β-Amyloid-Induced Calpain Activation and Tau Toxicity

Nicholson, A. M., & Ferreira, A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0862-09.2009 · Cited by 106 · see citing works

Hyaluronic Acid Receptor CD44 Deficiency Is Associated with Decreased Cryptococcus neoformans Brain Infection

Jong, A., Wu, C.-H., Gonzales-Gomez, I., Kwon-Chung, K. J., Chang, Y. C., Tseng, H.-K., Cho, W.-L., & Huang, S.-H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353375 · Cited by 100 · see citing works

Atorvastatin Prevents Hippocampal Cell Death due to Quinolinic Acid-Induced Seizures in Mice by Increasing Akt Phosphorylation and Glutamate Uptake

Piermartiri, T., Vandresen-Filho, S., Herculano, B., Martins, W. C., Dal’Agnolo, D., Stroeh, E., Carqueja, C. L., Boeck, C. R., & Tasca, C. I. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9057-6 · Cited by 100 · see citing works

Effects of Acid and Lactone Forms of Eight HMG-CoA Reductase Inhibitors on CYP-Mediated Metabolism and MDR1-Mediated Transport

Sakaeda, T., Fujino, H., Komoto, C., Kakumoto, M., Jin, J.-S., Iwaki, K., Nishiguchi, K., Nakamura, T., Okamura, N., & Okumura, K. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9371-5 · Cited by 94 · see citing works

Effect of Cholesterol on Membrane Fluidity and Association of Aβ Oligomers and Subsequent Neuronal Damage: A Double-Edged Sword

Fernández-Pérez, E. J., Sepúlveda, F. J., Peters, C., Bascuñán, D., Riffo-Lepe, N., González-Sanmiguel, J., Sánchez, S. A., Peoples, R. W., Vicente, B., & Aguayo, L. G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00226 · Cited by 90 · see citing works

In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi: Synergistic interactions between statins and azoles

Nyilasi, I., Kocsubé, S., Krizsán, K., Galgóczy, L., Pesti, M., Papp, T., & Vágvölgyi, C. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.01972.x · Cited by 83 · see citing works

Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists

Scotti, E., Hong, C., Yoshinaga, Y., Tu, Y., Hu, Y., Zelcer, N., Boyadjian, R., de Jong, P. J., Young, S. G., Fong, L. G., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01469-10 · Cited by 77 · see citing works

Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients

Li, J., Pan, Y., Xu, J., Li, S., Wang, M., Quan, K., Meng, X., Li, H., Lin, J., Wang, Y., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.033152 · Cited by 71 · see citing works

Antifungal activity of statins againstAspergillusspecies

Qiao, J., Kontoyiannis, D. P., Wan, Z., Li, R., & Liu, W. Y. (2007) · Medical Mycology · doi:10.1080/13693780701397673 · Cited by 69 · see citing works

Decrease in the Number of Reported Cases of Zygomycosis among Patients with Diabetes Mellitus: A Hypothesis

Kontoyiannis, D. P. (2007) · Clinical Infectious Diseases · doi:10.1086/512817 · Cited by 69 · see citing works

Statins of Different Brain Penetrability Differentially Affect CSF PLTP Activity

Vuletic, S., Riekse, R. G., Marcovina, S. M., Peskind, E. R., Hazzard, W. R., & Albers, J. J. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000095679 · Cited by 66 · see citing works

Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects

Miida, T., Takahashi, A., & Ikeuchi, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.09.003 · Cited by 66 · see citing works

T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of stroke

Theodorou, G. L., Marousi, S., Ellul, J., Mougiou, A., Theodori, E., Mouzaki, Α., & Καρακάντζα, Μ. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03650.x · Cited by 65 · see citing works

Effect of Beta-Blocker Therapy on the Risk of Infections and Death after Acute Stroke – A Historical Cohort Study

Maier, I., Karch, A., Mikolajczyk, R., Bähr, M., & Liman, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116836 · Cited by 64 · see citing works

What initiates the formation of senile plaques? The origin of Alzheimer-like dementias in capillary haemorrhages

Stone, J. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.04.007 · Cited by 60 · see citing works

Atorvastatin Downregulates Tissue Plasminogen Activator-Aggravated Genes Mediating Coagulation and Vascular Permeability in Single Cerebral Endothelial Cells Captured by Laser Microdissection

Liu, X., Zhang, Z. G., Zhang, L., Morris, D. C., Kapke, A., Lü, M., & Chopp, M. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600227 · Cited by 59 · see citing works

Systematic review of the in vitro effects of statins on oral and perioral microorganisms

Ting, M., Whitaker, E. J., & Albandar, J. M. (2015) · European Journal Of Oral Sciences · doi:10.1111/eos.12239 · Cited by 57 · see citing works

HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol

Kleemann, R., & Kooistra, T. (2005) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/156800605774962077 · Cited by 54 · see citing works

Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons

Domoki, F., Kis, B., Gáspár, T., Snipes, J. A., Parks, J. S., Bari, F., & Busija, D. W. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00366.2008 · Cited by 53 · see citing works

Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel

Al-Kuraishy, H. M., Jabir, M. S., Al-Gareeb, A. I., Albuhadily, A. K., Albukhaty, S., Sulaiman, G. M., & Batiha, G. E. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102119 · Cited by 53 · see citing works

Coronary Risk Assessment and Management Options in Chronic Kidney Disease Patients Prior to Kidney Transplantation

Karthikeyan, V., & Ananthasubramaniam, K. (2009) · Current Cardiology Reviews · doi:10.2174/157340309788970342 · Cited by 47 · see citing works

Statin-mediated protective effects in the central nervous system: General mechanisms and putative role of stress proteins

Schmeer, C. W., Kretz, A., & Isenmann, S. (2006) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2006-00333 · Cited by 46 · see citing works

Transcriptional and Posttranscriptional Control of Cholesterol Homeostasis by Liver X ReceptorsPreprint

Tontonoz, P. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010702 · Cited by 46 · see citing works

Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations

Nyilasi, I., Kocsubé́, S., Krizsán, K., Galgóczy, L., Papp, T., Pesti, M., Nagy, K., & Vágvölgyi, C. (2013) · Medical Mycology · doi:10.3109/13693786.2013.828160 · Cited by 44 · see citing works

Chronic administration of atorvastatin induced anti-convulsant effects in mice: The role of nitric oxide

Moezi, L., Shafaroodi, H., Hassanipour, M., Fakhrzad, A., Hassanpour, S., & Dehpour, A. R. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.02.001 · Cited by 43 · see citing works

Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels

Horiuchi, Y., Hirayama, S., Soda, S., Seino, U., Kon, M., Ueno, T., Idei, M., Hanyu, O., Tsuda, T., Ohmura, H., et al. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3632 · Cited by 42 · see citing works

Calpain and Atherosclerosis

Miyazaki, T., Koya, T., Kigawa, Y., Oguchi, T., Lei, X., Kim‐Kaneyama, J., & Miyazaki, A. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14787 · Cited by 41 · see citing works

Probucol and Atorvastatin Decrease Urinary 8-Hydroxy-2'-deoxyguanosine in Patients with Diabetes and Hypercholesterolemia

Endo, K., Miyashita, Y., Sasaki, H., Ebisuno, M., Ohira, M., Saiki, A., Koide, N., Oyama, T., Murano, T., & Shirai, K. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.68 · Cited by 41 · see citing works

Modulating effect of synthetic statins against damage induced by doxorubicin in somatic cells of Drosophila melanogaster

Orsolin, P. C., Oliveira, R. G. S., & Nepomuceno, J. C. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.04.004 · Cited by 39 · see citing works

Histone Deacetylase 3 Down-regulates Cholesterol Synthesis through Repression of Lanosterol Synthase Gene Expression

Villagra, A., Natalia Ulloa, M., Zhang, X. M., Yuan, Z., Sotomayor, E. M., & Seto, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701719200 · Cited by 38 · see citing works

Statin therapy and plasma cortisol concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials

Sahebkar, A., Rathouska, J., Simental‐Mendía, L. E., & Nachtigal, P. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.013 · Cited by 37 · see citing works

DFT study on hydroxy acid–lactone interconversion of statins: the case of fluvastatin

Grabarkiewicz, T., Grobelny, P. J., Hoffmann, M., & Mielcarek, J. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b612999b · Cited by 36 · see citing works

Atherosclerosis and acute coronary syndromes

Gotlieb, A. I. (2005) · Cardiovascular Pathology · doi:10.1016/j.carpath.2005.03.007 · Cited by 36 · see citing works

DFT study on hydroxy acid–lactone interconversion of statins: the case of atorvastatin

Hoffmann, M., & Nowosielski, M. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b803342k · Cited by 35 · see citing works

The effects of atorvastatin on memory deficit and seizure susceptibility in pentylentetrazole-kindled rats

Üzüm, G., Akgün‐Dar, K., & Aksu, U. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.07.024 · Cited by 35 · see citing works

In vitro interactions between primycin and different statins in their effects against some clinically important fungi

Nyilasi, I., Kocsubé, S., Pesti, M., Lukács, G., Papp, T., & Vágvölgyi, C. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.013946-0 · Cited by 35 · see citing works

Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Clark, U. S., & Cohen, R. A. (2010) · PubMed · Cited by 34 · see citing works

Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro

Natesan, S. K., Chandrasekar, P. H., Alangaden, G. J., & Manavathu, E. K. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.10.015 · Cited by 32 · see citing works

Vascular health and cognitive function in older adults with cardiovascular disease

Forman, D. E., Cohen, R. A., Hoth, K. F., Haley, A. P., Poppas, A., Moser, D. J., Gunstad, J., Paul, R. H., Jefferson, A. L., Tate, D. F., et al. (2008) · Artery Research · doi:10.1016/j.artres.2008.01.001 · Cited by 30 · see citing works

Cholesterol intake and statin use regulate neuronal G protein-gated inwardly rectifying potassium channels

Bukiya, A. N., Blank, P. S., & Rosenhouse‐Dantsker, A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m081240 · Cited by 27 · see citing works

Autocrine amplification loop in statin‐induced apoptosis of human melanoma cells

Minichsdorfer, C., & HOHENEGGER, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00298.x · Cited by 28 · see citing works

Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3

Bruder-Nascimento, T. B., Callera, G. E., Montezano, A. C., Antunes, T. T., He, Y., Cat, A. N. D., Ferreira, N. S., Barreto, P. A. P. M., Olivon, V. C., Tostes, R. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162731 · Cited by 27 · see citing works

Can statin therapy really reduce the risk of Alzheimerʼs disease and slow its progression?

Miida, T., Takahashi, A., Tanabe, N., & Ikeuchi, T. (2005) · Current Opinion in Lipidology · doi:10.1097/01.hjh.0000191246.68443.ff · Cited by 27 · see citing works

Cognitive Function and Antihypertensive Treatment in the Elderly: A 6-Year Follow-up Study

Paran, E., Anson, O., & Lowenthal, D. T. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181bf325c · Cited by 26 · see citing works

Effects of short term atorvastatin treatment on cerebral hemodynamics in CADASIL

Peters, N., Freilinger, T. M., Opherk, C., Pfefferkorn, T., & Dichgans, M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.04.015 · Cited by 26 · see citing works

A SNP of NPC1L1 Affects Cholesterol Absorption in Japanese

Maeda, T., Honda, A., Ishikawa, T., Kinoshita, M., Mashimo, Y., Takeoka, Y., Yasuda, D., Kusano, J., Tsukamoto, K., Matsuzaki, Y., et al. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.2451 · Cited by 26 · see citing works

Atorvastatin Upregulates the Expression of miR-126 in Apolipoprotein E-knockout Mice with Carotid Atherosclerotic Plaque

Pan, X., Hou, R., Ma, A., Wang, T., Wu, M., Zhu, X., Yang, S., & Xiao, X. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0331-x · Cited by 25 · see citing works

Alternative treatment of fungal infections: Synergy with non‐antifungal agents

Rossato, L. L., dos Santos, M. C., Vitale, R. G., de Hoog, S., & Ishida, K. (2020) · Mycoses · doi:10.1111/myc.13203 · Cited by 27 · see citing works

Statins in Unconventional Secretion of Insulin-Degrading Enzyme and Degradation of the Amyloid-β Peptide

Glebov, K., & Walter, J. (2011) · Neurodegenerative Diseases · doi:10.1159/000332595 · Cited by 25 · see citing works

The Effect of Simvastatin on Erythrocyte Membrane Fluidity During Oxidative Stress Induced by Cardiopulmonary Bypass: A Randomized Controlled Study

Coccia, R., Spadaccio, C., Foppoli, C., Marzia Perluigi, A., Covino, E., Lusini, M., & Chello, M. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.08.010 · Cited by 25 · see citing works

Antifungal activity of statins and their interaction with amphotericin B against clinically important Zygomycetes

Galgóczy, L., Lukács, G., Nyilasi, I., Papp, T., & Vágvölgyi, C. (2010) · Acta Biologica Hungarica · doi:10.1556/abiol.61.2010.3.11 · Cited by 23 · see citing works

Anticonvulsive effect of atorvastatin on pentylenetetrazole‐induced seizures in mice: the role of nitric oxide pathway

Moazzami, K., Emamzadehfard, S., & Shabani, M. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2012.01038.x · Cited by 23 · see citing works

Statins as antifungal agents

Galgóczy, L. (2011) · World Journal of Clinical Infectious Diseases · doi:10.5495/wjcid.v1.i1.4 · Cited by 21 · see citing works

Effect of Atorvastatin on PM 10 -induced Cytokine Production by Human Alveolar Macrophages and Bronchial Epithelial Cells

Sakamoto, N., Hayashi, S., Mukae, H., Vincent, R., Hogg, J. C., & van Eeden, S. F. (2009) · International Journal of Toxicology · doi:10.1177/1091581809333140 · Cited by 20 · see citing works

Atorvastatin and rosuvastatin improve physiological parameters and alleviate immune dysfunction in metabolic disorders

Lee, S., Lee, Y. J., Kim, J., An, J., Kim, K., Lee, H., Kong, H., Song, Y., & Kim, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.101 · Cited by 20 · see citing works

Pharmacology of vascular endothelium

Gryglewski, R. J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04725.x · Cited by 20 · see citing works

Ezetimibe decreases serum oxidized cholesterol without impairing bile acid synthesis in Japanese hypercholesterolemic patients

Hirayama, S., Nakagawa, S., Soda, S., Kamimura, Y., Nishioka, E., Ueno, T., Fukushima, Y., Higuchi, K.-I., Inoue, M., Seino, U., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.06.016 · Cited by 17 · see citing works

Statin post-treatment provides protection against simulated ischemia in bovine pulmonary arterial endothelial cells

Wu, X., Lin, D., Li, G., & Zuo, Z. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.028 · Cited by 16 · see citing works

Protection against the Neurotoxic Effects of β-Amyloid Peptide on Cultured Neuronal Cells by Lovastatin Involves Elevated Expression of α7 Nicotinic Acetylcholine Receptors and Activating Phosphorylation of Protein Kinases

Zhao, L., Xiao, Y. C., Xiu, J., Tan, L.-C., & Guan, Z. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.11.020 · Cited by 15 · see citing works

<i>In vitro</i> interaction between suramin and fluvastatin against clinically important Zygomycetes

Galgóczy, L., Papp, T., & Vágvölgyi, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2008.01634.x · Cited by 14 · see citing works

Hypolipidaemic and anti-inflammatory effects of fixed dose combination of atorvastatin plus ezetimibe in Indian patients with dyslipidaemia

Padhy, B., Yadav, R., & Gupta, Y. K. (2013) · Singapore Medical Journal · doi:10.11622/smedj.2013031 · Cited by 8 · see citing works

Blood Pressure and Statin Effects on Cognition: a Review

Yang, M., & Williamson, J. D. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0973-4 · Cited by 8 · see citing works

Higher Small Arterial Elasticity in Hypertensive Patients Treated with Angiotensin II Receptor Blockers

Takeuchi, K., Ideishi, M., Tashiro, T., Morishige, N., Yamada, T., Saku, K., & Urata, H. (2005) · Hypertension Research · doi:10.1291/hypres.28.639 · Cited by 8 · see citing works

Autophagy-urea cycle pathway is essential for the statin-mediated nitric oxide bioavailability in endothelial cells

Chen, W., Guo, B., Chen, C., Hsu, M., Wang, C., & Lee, T. (2023) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.3472 · Cited by 6 · see citing works

Theoretical study of hydrogen bond interactions of fluvastatin with ι-carrageenan and λ-carrageenan

Papadopoulos, A. G., & Sigalas, M. P. (2010) · Journal of Molecular Modeling · doi:10.1007/s00894-010-0878-2 · Cited by 6 · see citing works

Enzymatic Targets in Atherosclerosis

VG, F. E. T., & AV, R. C. G. (2015) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000176 · Cited by 5 · see citing works

Clopidogrel “resistance” and statin cotreatment – significant for cardiocoronary prevention in real life?

Weber, A., Hohlfeld, T., & Schrör, K. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-07-0468 · Cited by 5 · see citing works

Cholesterol Lowering and Beyond: Role of Statins in Alzheimer’s Disease

Rebollo, A., Pou, J., & Alegret, M. (2008) · Aging Health · doi:10.2217/1745509x.4.2.171 · Cited by 3 · see citing works

Long-term efficacy of atorvastatin in allograft rejection following renal transplantation: A randomized clinical trial

Hosseini, A., Gholiaf, M., Dadras, F., Khoshjoo, F., & Amirzargar, M. A. (2015) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.164576 · Cited by 2 · see citing works

The Blood-Brain Barrier: Targeting in the Pathogenesis of C. neoformans Meningitis and Drug Discovery

Tseng, H.-K., Huang, S., Shackleford, G. M., & Jong, A. (2013) · Anti-Infective Agents · doi:10.2174/2211352511311020005 · Cited by 2 · see citing works

Encuesta sobre el manejo de dislipidemia con estatinas en México: Porcentaje de pacientes que alcanzan las metas establecidas por el Programa Nacional de Educación en Colesterol (National Cholesterol Education Program [NCEP])

Gonzalez, C. A., Pavía, A., Redding, F. J., Zacarías, J., Ramírez, M. Á., Salazar, M. A., Aspe, J., Carranza, J., Barba, R., Ramı́rez, J. C., et al. (2009) · Cited by 1 · see citing works

Rosuvastatin Induces Delayed Preconditioning Against Oxygen-glucose Deprivation In Cultured Cortical Neurons

David, B. (2009) · Frontiers in Systems Neuroscience · doi:10.3389/conf.neuro.01.2009.04.148 · Cited by 1 · see citing works

Aspirin and statin medication decreases the risk of myocardial infarction associated with LTA and NFKBIL1 polymorphisms

Höyssä, S., Rontu, R., Kuukasjärvi, P., Mennander, A., Laurikka, J. O., Tarkka, M. R., Nikus, K. C., Islam, M., Karhunen, P. J., & Lehtimäki, T. J. (2006) · Open Medicine · doi:10.2478/s11536-006-0026-7 · Cited by 1 · see citing works

Investigação do efeito neuroprotetor da atorvastatina em um modelo in vitro de toxicidade induzida pelo peptídeo β-amiloide

da Silva, T. (2012) · Americanae (AECID Library)

ESTUDO BIOQUÍMICO E COMPORTAMENTAL EM CAMUNDONGOS SUBMETIDOS À INFUSÃO INTRACEREBROVENTRICULAR DOS PEPTÍDEOS BETA-AMILÓIDE Aβ1-40 E Aβ25-35 E O PAPEL NEUROPROTETOR DA ATORVASTATINA

Tasca, C. I. (2009)

Hypolipidemic Therapy

Loktionov, A. (2006) · Nutrition and disease prevention · doi:10.1201/9781420019131.ch2

Avaliação do efeito modulador de diferentes estatinas sobre danos ao DNA induzidos pela doxorrubicina em células somáticas de Drosophila melanogaster

Orsolin, P. C. (2015) · doi:10.14393/ufu.te.2015.94

Evaluation of lipid lowering ability of atorvastatin and ezetimibe combination as compared with atorvastatin monotherapy

Dudhal, K. S., Bapat, T. R., & Bansode, A. A. (2017) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20172723

RhoC in melanoma: possible target for statin treatment

Malfait, T. L. A. (2010) · Submitted in <b>2010</b>

Transcriptional and Posttranscriptional Control of Cholesterol Homeostasis by Liver X Receptors

Ontonoz, P. T. (2011)

Involvement of cholesterol and β-amyloid in the initiation and progression of Alzheimer’s disease

Aguayo, L. G., Roa, J., Burgos, C. F., & González-Sanmiguel, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00039-0

Synergistic neuroprotective effects of the ROCK inhibitor Y27632 and atorvastatin in optineurin-E50K-mutant mice through inhibition of scleral fibroblast transdifferentiation

Zhu, X., Liu, X., Xu, X., Ding, Z., Zhang, S., Wang, Q., Zhang, D., Qiu, L., Chen, S., Du, M., et al. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110760

Statins and Myasthenia Gravis: Clinical Implications and Pathogenesis

Tian, X., & Zhang, P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188150

Prevention of stroke and dementia with statins

Vaughan, C. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03270-8 · Cited by 139 · see citing works

Statins: the new aspirin?

Veillard, N. R., & Mach, F. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012505 · Cited by 106 · see citing works

New Insights into the Pleiotropic Effects of Statins for Stroke Prevention

Pezzini, A., Zotto, E. D., Volonghi, I., Giossi, A., Costa, P., & Padovani, A. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788452658 · Cited by 16 · see citing works

Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects

Miida, T., Takahashi, A., & Ikeuchi, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.09.003 · Cited by 66 · see citing works

Vascular effects of statins in stroke.

Delanty, N., & Vaughan, C. J. (1997) · Stroke · doi:10.1161/01.str.28.11.2315 · Cited by 163 · see citing works